Michael A. Chirigos

3.5k total citations
111 papers, 2.8k citations indexed

About

Michael A. Chirigos is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Michael A. Chirigos has authored 111 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Immunology, 36 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Michael A. Chirigos's work include Immunotherapy and Immune Responses (19 papers), Immune Cell Function and Interaction (17 papers) and Virus-based gene therapy research (11 papers). Michael A. Chirigos is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), Immune Cell Function and Interaction (17 papers) and Virus-based gene therapy research (11 papers). Michael A. Chirigos collaborates with scholars based in United States, Malaysia and Italy. Michael A. Chirigos's co-authors include Richard M. Schultz, Joseph Papamatheakis, Nicholas Pavlidis, Stephen J. Mohr, William A. Stylos, Sidney Udenfriend, Paul Greengard, Abraham Goldin, Stewart R. Humphreys and Allan L. Goldstein and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael A. Chirigos

110 papers receiving 2.5k citations

Peers

Michael A. Chirigos

IMMUN

ONCOL

PHARM

Yuichi Yamamura Japan

Yûichi Yamamura Japan

Dennis E. Van Epps United States

Den’ichi Mizuno Japan

Ganesh M. Sathe United States

Naoki Koide Japan

L. Fiume Italy

William B. Cowden Australia

Rachel Goldman Israel

Denis J. Schrier United States

Yuichi Yamamura Japan

Michael A. Chirigos

938 ×1.0

IMMUN

1.4k ×1.8

425 ×0.8

ONCOL

307 ×0.8

136 ×0.4

PHARM

Citations per year, relative to Michael A. Chirigos Michael A. Chirigos (= 1×) peers Yuichi Yamamura

Countries citing papers authored by Michael A. Chirigos

Since Specialization

Citations

This map shows the geographic impact of Michael A. Chirigos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Chirigos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Chirigos more than expected).

Fields of papers citing papers by Michael A. Chirigos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Chirigos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Chirigos. The network helps show where Michael A. Chirigos may publish in the future.

Co-authorship network of co-authors of Michael A. Chirigos

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Chirigos. A scholar is included among the top collaborators of Michael A. Chirigos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Chirigos. Michael A. Chirigos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buckheit, Robert W., et al.. (1993). Differential Antiviral Activity of Two TIBO Derivatives Against the Human Immunodeficiency and Murine Leukemia Viruses Alone and in Combination with Other Anti-HIV Agents. AIDS Research and Human Retroviruses. 9(11). 1097–1106. 16 indexed citations

Buckheit, Robert W., E. Lucile White, William M. Shannon, et al.. (1992). Significant Anti-HIV Activity of New Modified Poly Anionic Polymersin vitro. Immunopharmacology and Immunotoxicology. 14(4). 707–721. 1 indexed citations

Morrey, John D., et al.. (1991). Effect of imexon treatment on friend virus complex infection using genetically defined mice as a model for HIV-1 infection. Antiviral Research. 15(1). 51–65. 11 indexed citations

Piccoli, Mario, Giorgio Santoni, Angela Santoni, et al.. (1991). Inhibition of NK Cell Generation by Corynebacterium Parvum. Immunopharmacology and Immunotoxicology. 13(4). 513–529. 1 indexed citations

Chirigos, Michael A., Michael A. Ussery, J Rankin, et al.. (1990). Antiviral Efficacy of Imexon in the Rauscher Murine Retrovirus Aids Model. Immunopharmacology and Immunotoxicology. 12(1). 1–21. 15 indexed citations

Chirigos, Michael A. & Myra L. Patchen. (1988). Survey of newer biological response modifiers for possible use in radioprotection. Pharmacology & Therapeutics. 39(1-3). 243–246. 11 indexed citations

Patchen, Myra L., et al.. (1988). Radioprotection by biological response modifiers alone and in combination with WR-2721. Pharmacology & Therapeutics. 39(1-3). 247–254. 22 indexed citations

Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.. PubMed. 45(3). 1058–65. 42 indexed citations

Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.. PubMed. 45(3). 1066–72. 27 indexed citations

10.

Saito, Tohru, et al.. (1985). Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers. Cancer Immunology Immunotherapy. 19(2). 130–5. 19 indexed citations

11.

Bartocci, A., et al.. (1982). Enhancing activity of various immunoaugmenting agents on the delayed-type hypersensitivity response in mice.. Cancer Research. 42(9). 3514–8. 6 indexed citations

12.

Hersh, Evan M., Michael A. Chirigos, & Michael J. Mastrangelo. (1981). Augmenting agents in cancer therapy. 33(6). 261–265. 40 indexed citations

13.

Chirigos, Michael A.. (1981). Mediation of cellular immunity in cancer by immune modifiers. Raven Press eBooks. 8 indexed citations

14.

Goldstein, Allan L. & Michael A. Chirigos. (1981). Lymphokines and thymic hormones : their potential utilization in cancer therapeutics. Raven Press eBooks. 49 indexed citations

15.

Chirigos, Michael A.. (1978). Immune modulation and control of neoplasia by adjuvant therapy. Raven Press eBooks. 114 indexed citations

16.

Mohr, Stephen J., Judith G. Massicot, & Michael A. Chirigos. (1978). Drepression of nuclear template restrictions for DNA synthesis by the immunostimulator pyran copolymer.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(6). 1610–6. 1 indexed citations

17.

Mikulski, Stanislaw M., Michael A. Chirigos, & Franco M. Muggia. (1978). Immune Modulation and Cancer Control. Advances in pharmacology. 15. 263–287. 5 indexed citations

18.

Chirigos, Michael A.. (1977). Control of neoplasia by modulation of the immune system. Raven Press eBooks. 99 indexed citations

19.

Chirigos, Michael A., Frank J. Rauscher, Ismail A. Kamel, G R Fanning, & Abraham Goldin. (1963). STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA.. PubMed. 23. 1646–50. 9 indexed citations

20.

Chirigos, Michael A., Paul Greengard, & Sidney Udenfriend. (1960). Uptake of Tyrosine by Rat Brain in Vivo. Journal of Biological Chemistry. 235(7). 2075–2079. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact